Navigation Links
Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:2/1/2008

CORONA, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, February 5, 2008 at 1:40 p.m. Eastern Standard Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL: http://www.veracast.com/webcasts/ml/globalpharma08/37109138.cfm

An archived version will be available for 14 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
5. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. American Oriental Bioengineering to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Alexzas Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference
11. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...TON,Nov.24/PRNewswire-FirstCall/--IES(Nasdaq: IESC...ationssystemsandservicesforthecommercial,industria...cialbusinessgrouphasbeenawardedacontractfromManhat...l4bio-safetylab(BSL-4)replacementfacilityattheU.S....SAMRIID)atFortDetrickinFrederick,Md. ,, ThenewU...
(Date:11/24/2009)...JAVIK,Iceland,November24/PRNewswire-FirstCall/--de...tithasreceivednoticefrom,theNasdaqStockMarketthatt...fNovember30,2009andaForm25-NSEwillbefiledwiththe,S...DE,scommonstock,fromlistingonNasdaq,unlessthecompa...nel.Thecompanyhasfiledsuchanappeal,which,willstayt...
(Date:11/24/2009)...ATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neuroges...usedondevelopingandcommercializingnovelpainmanagem...identandChiefExecutiveOfficer,isscheduledtopresent...beheldDecember1-2,2009atTheNewYorkPalaceHotelinNew...ChiefFinancialOfficer,willbeavailabletorespondtoqu...
(Date:11/24/2009)...ENTURE:HTL , TORONTO,Nov.24/PRNewswire-FirstC...CapitalInc.,aleadingproviderofadvancedlasersystems...inicmarkets,todayreportedoperationalandfinancialre...Q32009Highlights,-Revenuewas$1.46millioncomparedw...ercentcomparedwith66.1percentinQ3,2008,-Netlossred...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...Biosciences,(Nasdaq: NBIX ) announces the followi... Quarter 2008 Financial Results, When: October...: http://www.videonewswire.com/event.asp?id=527...g on to the web at the address above., ...re unable to participate during the live webcast, ...
... increasing global demand for health ...Oct. 28 Boston Healthcare Associates, Inc.,today ...esident., Mr. Barak brings 16 years of pricing an...nt of global pricing and reimbursement strategies,...ide range of therapeutic,areas including oncology,...
...on of Enrollment in U.S. Phase II Study,of Nitazox...atitis C,Genotype 1, TAMPA, Fla., Oct. 28 Romark...company, today announced the presentation of studi...ting of the American,Association for the Study of ...eting(R), and the 50th Anniversary Meeting of the ...
Other Biology Technology:Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability 2Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco 2
(Date:11/24/2009)... is available in Spanish . , The presence o...of inflammatory substances in the blood, hinders t...y a research project of the University of Navarra ... at the School of Pharmacy. , The project, entit...tion to the control of body weight and inflammatio...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
(Date:11/23/2009)...lif. - By producing some of the highest resolution... scientists have a deeper understanding how biomol...ch may lead to a new treatment for kidney stones u... in the Nov. 23 online edition of the journal Pro...lores how peptides interact with mineral surfaces ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 1Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 2Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 1As Biking Popularity Grows so Must the Spotlight on Safety 48031 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 3
...ay not have to look any further than his or her ow... to a study published in the November issue of The...prepared platelets taken from the patient which ar... elbow provides more relief than more commonly-use...ten resulting in surgery, concludes study authors ...
... from the leading cause of blindness in western so.... , With the aid of a new eye instrument, they ha...ndows Popeye with his super-human strength could a... for spectacles! , Spinach and some other vegeta... a chemical called lutein, which, together with an...
...re than virtually any other type of therapy, has g...nt success but also great concerns regarding healt... (German Research Foundation, DFG) issued its firs...eveloped enormously. , Wide-ranging experiments h... risks of gene therapy. The second memorandum, whi...
Other Biology News:New biologic treatment for tennis elbow may replace surgery for chronic sufferers 2New biologic treatment for tennis elbow may replace surgery for chronic sufferers 3Why Popeye only has eyes for spinach 2Development of gene therapy 2
Canine IFN-gamma ELISA Kit from R&D Systems
Bovine Serum Albumin Peroxidase Stabilizer Solution from BioFX Laboratories, Inc.
...se-digesting enzyme isolated from Pseudomonas atla...bonds in agarose producing carbohydrate molecules ... molecules will not interfere with subsequent DNA ... be used for restriction endonuclease digestions l...
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: